Overview
Financials
Revenue history
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 400 days for 2023).
- 202508/07/2026
- 202419/08/2025
- 202319/08/2025
- 202226/03/2024
- 202107/10/2022
- 202017/09/2021
The statements for 2021 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board is entitled to make declarations of will on behalf of the company independently. In the case of a multi-member management board, the President of the Management Board is entitled to make declarations of will on behalf of the company independently, or joint action by two Vice-Presidents of the Management Board is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mariusz Paździorage 50 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Powerpharmasp. z o.o. | – | powerpharma.eu |
FAQ
Last updated: 2026-07-08